Compare GEL & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEL | AORT |
|---|---|---|
| Founded | 1996 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 1996 | 1996 |
| Metric | GEL | AORT |
|---|---|---|
| Price | $17.69 | $35.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $19.50 | ★ $48.76 |
| AVG Volume (30 Days) | 266.6K | ★ 450.2K |
| Earning Date | 05-12-2026 | 05-15-2026 |
| Dividend Yield | ★ 4.07% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.21 |
| Revenue | ★ $2,912,770,000.00 | $298,836,000.00 |
| Revenue This Year | $12.12 | $13.95 |
| Revenue Next Year | N/A | $11.16 |
| P/E Ratio | ★ N/A | $168.33 |
| Revenue Growth | ★ 43.60 | 18.01 |
| 52 Week Low | $11.87 | $21.97 |
| 52 Week High | $18.16 | $48.25 |
| Indicator | GEL | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 63.73 | 32.14 |
| Support Level | $16.21 | $33.85 |
| Resistance Level | N/A | $44.29 |
| Average True Range (ATR) | 0.53 | 1.50 |
| MACD | 0.03 | -0.11 |
| Stochastic Oscillator | 88.07 | 37.57 |
Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.